Leo A. Kim, MD, PhD

Researchers identify new target for abnormal blood vessel growth in the eyes

April 11, 2017

Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.

Boston, Mass.— A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative diabetic retinopathy).... Read more about Researchers identify new target for abnormal blood vessel growth in the eyes

Jason Comander and Leo Kim discuss vision research with members of Congress

Jason Comander and Leo Kim discuss vision research with members of Congress

October 13, 2015

On October 7th and 8th, Jason Comander, MD, PhD, and Leo Kim, MD, PhD, participated in the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program. This program allows scientists to meet with members of Congress to discuss the importance of vision research in the continuing fight to prevent blindness. 

Dr...

Read more about Jason Comander and Leo Kim discuss vision research with members of Congress